1138 / 1241
PET-Plan: Endpoints
primary
local progression free survival
secondary
toxicity (CTC; RTOG/EORTC)
doses to PTV reached by escalation
biometry
one-sided test; α=0,025, Power 80%
primary analysis: non-inferiority
secondary analysis: superiority of arm B